Oramed Receives $18M Payment, Approves $0.25 Dividend

miércoles, 7 de enero de 2026, 9:21 am ET1 min de lectura
ORMP--

Oramed Pharmaceuticals (ORMP) received an $18 million payment from Scilex Holdings, completing Scilex's obligations under an option agreement. This payment brings Oramed's total returns from the Scilex investment to $118 million. Oramed also approved a $0.25 per share dividend.

Oramed Receives $18M Payment, Approves $0.25 Dividend

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios